A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Maxim Pharmaceuticals

About Maxim Pharmaceuticals

Maxim Pharmaceuticals is a biopharmaceutical company dedicated to developing therapeutic candidates to treat cancer and liver disease. Using its proprietary live cell high-throughput screening technology and chemical genetics, Maxim is developing small-molecule apoptosis inducers to treat cancer. This program has produced several lead compounds that are advancing to clinical trials through collaborations or independently. Maxim is also continuing to screen compound libraries to identify new compounds. Ceplene™, Maxim’s histamine based drug candidate, administered in combination with IL-2 as a remission maintenance therapy, demonstrated an improvement in leukemia free survival in one Phase 3 study of Acute Myeloid Leukemia patients compared to patients receiving no treatment, the current standard of care. Apoptosis compounds and Ceplene are investigational drugs and have not been approved by the U.S. Food and Drug Administration or any international regulatory agency.


Pipeline for Maxim


Ceplene -- Advanced Melanoma, Acute Myeloid Leukemia, Renal Cell Carcinoma, Hepatitis C

MX8899 -- Oral Mucositis, Radiation Dermatitis


Cinical Trial Information



More on Maxim

Home Page

Key Statistics for Maxim

Basic Chart for Maxim

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.